How can high-performance computing clusters benefit precision medicine?
Posted by Gareth Harwood
Originally published, April 30, 2018, from Embedded Intel® Solutions
In genomics, huge data files are generated, which are then broken down into thousands of smaller fragments for effective analytics. Today this kind of precision medicine is advancing because clinicians can access and interpret these data files—patient information in the form of genetic sequences—faster than ever. This is High Performance Computing (HPC) cluster technology at work, delivering remarkable benefits for individual patients and helping advance the field of genomics decades faster than originally anticipated. Where precision medicine was thought to have global impact by 2050, the new target is 2020. ‘One size fits all’ is no longer the standard of care, and HPC technology is poised to deliver higher value at lower costs in the widest range of research and treatment environments.
Tapping into Big Data Faster
It once took weeks to benefit from healthcare data—collaborating and sharing data from labs, medical records, pharmacies, insurance companies, and specialists, and then turning that information into well-informed treatment plans. HPC cluster architecture has cut this timeline down to a matter of hours. As exciting as that is, the real value is that this scalable, standards-based technology is accessible to hospitals, clinics, and labs of all sizes and resources, instead of just government labs and super-computing environments. On a global basis, the spectrum of healthcare innovators can tap into HPC to increase the value of data while significantly lowering their costs. Reactions to treatments are faster and more responsive, saving lives in all types of treatment settings.
To read the full article, visit the original published article here.